نتایج جستجو برای: ژن mecp2

تعداد نتایج: 17535  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Dag H Yasui Sailaja Peddada Mark C Bieda Roxanne O Vallero Amber Hogart Raman P Nagarajan Karen N Thatcher Peggy J Farnham Janine M Lasalle

Mutations in MECP2 cause the autism-spectrum disorder Rett syndrome. MeCP2 is predicted to bind to methylated promoters and silence transcription. However, the first large-scale mapping of neuronal MeCP2-binding sites on 26.3 Mb of imprinted and nonimprinted loci revealed that 59% of MeCP2-binding sites are outside of genes and that only 6% are in CpG islands. Integrated genome-wide promoter an...

Journal: :IUBMB life 2010
Jeffrey C Hansen Rajarshi P Ghosh Christopher L Woodcock

Methylated CpG Binding Protein 2 (MeCP2) is a nuclear protein named for its ability to selectively recognize methylated DNA. Much attention has been focused on understanding MeCP2 structure and function in the context of its role in Rett syndrome, a severe neurodevelopmental disorder that afflicts one in 10,000-15,000 girls. Early studies suggested a connection between DNA methylation, MeCP2, a...

2016
Azumi Suzuki Masamichi Shinoda Kuniya Honda Tetsuro Shirakawa Koichi Iwata

BACKGROUND Pain hypoalgesia has been reported in Rett syndrome patients, a severe neurodevelopmental disorder which can be attributed to mutations in the methyl-CpG binding protein 2 (MeCP2). Here, we examined the role of MeCP2 signaling in tongue heat sensitivity in the normal and inflamed state using Mecp2 heterozygous (Mecp2(+/-)) mice. RESULTS Heat hypoalgesia of the tongue occurred in Me...

Journal: :Neuron 2007
Hsiao-Tuan Chao Huda Y. Zoghbi Christian Rosenmund

MeCP2 is a transcriptional repressor critical for normal neurological function. Prior studies demonstrated that either loss or doubling of MeCP2 results in postnatal neurodevelopmental disorders. To understand the impact of MeCP2 expression on neuronal function, we studied the synaptic properties of individual neurons from mice that either lack or express twice the normal levels of MeCP2. Hippo...

Journal: :Neurobiology of Disease 2014
Paolo Petazzi Naiara Akizu Alejandra García Conchi Estarás Alexia Martínez de Paz Manuel Rodríguez-Paredes Marian A. Martínez-Balbás Dori Huertas Manel Esteller

Epigenetic mechanisms are fundamental for shaping the activity of the central nervous system (CNS). Methyl-CpG binding protein 2 (MECP2) acts as a bridge between methylated DNA and transcriptional effectors responsible for differentiation programs in neurons. The importance of MECP2 dosage in CNS is evident in Rett Syndrome and MECP2 duplication syndrome, which are neurodevelopmental diseases c...

Journal: :Human molecular genetics 2006
Sailaja Peddada Dag H Yasui Janine M LaSalle

Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder caused by mutations in MECP2, encoding methyl-CpG-binding protein 2. MeCP2 is a transcriptional repressor elevated in mature neurons and is predicted to be required for neuronal maturation by regulating multiple target genes. Identifying primary gene targets in either Mecp2-deficient mice or human RTT brain has proven to be...

Journal: :Brain research 2008
Emmanuelle Dura Laurent Villard Jean-Christophe Roux

Methyl CpG binding protein 2 (MeCP2) is a member of the methylated DNA binding protein family able to modulate the transcription of target genes. Mutations in MECP2 lead to a wide range of neurological phenotypes and the better known of these diseases is Rett Syndrome. All patients having a mutation in MECP2 are mentally retarded and most of them exhibit dysfunctions in autonomic processes that...

2014
Claudio De Felice Floriana Della Ragione Cinzia Signorini Silvia Leoncini Alessandra Pecorelli Lucia Ciccoli Francesco Scalabrì Federico Marracino Michele Madonna Giuseppe Belmonte Laura Ricceri Bianca De Filippis Giovanni Laviola Giuseppe Valacchi Thierry Durand Jean-Marie Galano Camille Oger Alexandre Guy Valérie Bultel-Poncé Jacky Guy Stefania Filosa Joussef Hayek Maurizio D'Esposito

Rett syndrome (RTT) is a rare neurodevelopmental disorder affecting almost exclusively females, caused in the overwhelming majority of the cases by loss-of-function mutations in the gene encoding methyl-CpG binding protein 2 (MECP2). High circulating levels of oxidative stress (OS) markers in patients suggest the involvement of OS in the RTT pathogenesis. To investigate the occurrence of oxidat...

Journal: :Human molecular genetics 2013
Min Lang Robert G Wither Jonathan M Brotchie Chiping Wu Liang Zhang James H Eubanks

Rett syndrome (RTT) is a neurodevelopmental disorder caused primarily by mutations of the X-linked MECP2 gene. Although the loss of MeCP2 function affects many neural systems, impairments of catecholaminergic function have been hypothesized to underlie several of the cardinal behavioral deficits of RTT patients and Mecp2-deficient mice. Although recent Mecp2 reactivation studies indicate that R...

Journal: :Cancer discovery 2016
Manish Neupane Allison P Clark Serena Landini Nicolai J Birkbak Aron C Eklund Elgene Lim Aedin C Culhane William T Barry Steven E Schumacher Rameen Beroukhim Zoltan Szallasi Marc Vidal David E Hill Daniel P Silver

UNLABELLED An unbiased genome-scale screen for unmutated genes that drive cancer growth when overexpressed identified methyl cytosine-guanine dinucleotide (CpG) binding protein 2 (MECP2) as a novel oncogene. MECP2 resides in a region of the X-chromosome that is significantly amplified across 18% of cancers, and many cancer cell lines have amplified, overexpressed MECP2 and are dependent on MECP...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید